Myelin Proteolipid Protein
"Myelin Proteolipid Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. (From Siegel et al., Basic Neurochemistry, 4th ed, p122)
| Descriptor ID |
D018991
|
| MeSH Number(s) |
D10.570.780.500 D12.776.543.620.580 D12.776.631.580.580 D12.776.816.500
|
| Concept/Terms |
Myelin Proteolipid Protein- Myelin Proteolipid Protein
- Folch-Lees Protein
- Folch Lees Protein
- Protein, Folch-Lees
- Proteolipid Protein, Myelin
- Protein, Myelin Proteolipid
- Folch-PI Proteolipid Protein
- Folch PI Proteolipid Protein
- Protein, Folch-PI Proteolipid
- Proteolipid Protein, Folch-PI
- Myelin PLP
- PLP, Myelin
|
Below are MeSH descriptors whose meaning is more general than "Myelin Proteolipid Protein".
Below are MeSH descriptors whose meaning is more specific than "Myelin Proteolipid Protein".
This graph shows the total number of publications written about "Myelin Proteolipid Protein" by people in this website by year, and whether "Myelin Proteolipid Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelin Proteolipid Protein" by people in Profiles.
-
Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain. ASN Neuro. 2010 Sep 27; 2(4):e00043.
-
S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol. 2010 Jun; 5(2):240-51.
-
p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target. Neurochem Res. 2007 Feb; 32(2):293-302.
-
Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice. Neurochem Res. 2007 Feb; 32(2):343-51.
-
Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. 2006 May; 59(5):684-9.
-
Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex. J Neurosci. 2006 Mar 01; 26(9):2458-66.
-
5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol. 2005 Jul 01; 175(1):566-74.
-
Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol. 2004 Jan 15; 172(2):1273-86.
-
Selective alteration of the ventilatory response to hypoxia results from mutation in the myelin proteolipid protein gene. Adv Exp Med Biol. 2004; 551:85-91.
-
Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. J Chem Neuroanat. 2003 Oct; 26(2):119-24.